Literature DB >> 12169492

Polysaccharide pneumococcal vaccines.

Tom Jefferson, Vittorio Demicheli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12169492      PMCID： PMC1123818          DOI： 10.1136/bmj.325.7359.292

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

1.  Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials.

Authors:  C Cornu; D Yzèbe; P Léophonte; J Gaillat; J P Boissel; M Cucherat
Journal:  Vaccine       Date:  2001-09-14       Impact factor: 3.641

2.  Clinical effectiveness of pneumococcal vaccine. Meta-analysis.

Authors:  B G Hutchison; A D Oxman; H S Shannon; S Lloyd; C A Altmayer; K Thomas
Journal:  Can Fam Physician       Date:  1999-10       Impact factor: 3.275

Review 3.  Pneumococcal polysaccharide vaccine: a systematic review of clinical effectiveness in adults.

Authors:  Lorna Watson; Brenda J Wilson; Norman Waugh
Journal:  Vaccine       Date:  2002-05-22       Impact factor: 3.641

Review 4.  Pneumococcal vaccine for asthma.

Authors:  A Sheikh; B Alves; S Dhami
Journal:  Cochrane Database Syst Rev       Date:  2002

Review 5.  Assessing the potential cost effectiveness of pneumococcal vaccines in the US: methodological issues and current evidence.

Authors:  J Hutton; C Iglesias; T O Jefferson
Journal:  Drugs Aging       Date:  1999       Impact factor: 3.923

6.  Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials.

Authors:  M J Fine; M A Smith; C A Carson; F Meffe; S S Sankey; L A Weissfeld; A S Detsky; W N Kapoor
Journal:  Arch Intern Med       Date:  1994 Dec 12-26

Review 7.  Pneumococcal vaccines for preventing otitis media.

Authors:  M Straetemans; E A Sanders; R H Veenhoven; A G Schilder; R A Damoiseaux; G A Zielhuis
Journal:  Cochrane Database Syst Rev       Date:  2002
  7 in total
  5 in total

1.  Pneumonia due to antibiotic resistant Streptococcus pneumoniae and Pseudomonas aeruginosa in the HAART era.

Authors:  S H Allen; P Brennan-Benson; M Nelson; D Asboe; M Bower; B Azadian; B Gazzard; J Stebbing
Journal:  Postgrad Med J       Date:  2003-12       Impact factor: 2.401

2.  Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries.

Authors:  S M A A Evers; A J H A Ament; G L Colombo; H B Konradsen; R R Reinert; D Sauerland; K Wittrup-Jensen; C Loiseau; D S Fedson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-08       Impact factor: 3.267

3.  High serological response to pneumococcal vaccine in nephrotic children at disease onset on high-dose prednisone.

Authors:  Tim Ulinski; Sandrine Leroy; Marie Dubrel; Sylvie Danon; Albert Bensman
Journal:  Pediatr Nephrol       Date:  2008-03-07       Impact factor: 3.714

4.  Rapid decline of anti-pneumococcal antibody levels in nephrotic children.

Authors:  Ayfer Gür Güven; Sema Akman; Elif Bahat; Mustafa Senyurt; Selma Yüzbey; Aysen Uguz; Olcay Yegin
Journal:  Pediatr Nephrol       Date:  2003-11-25       Impact factor: 3.714

5.  The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003/2004.

Authors:  John D Mooney; Amanda Weir; Jim McMenamin; Lewis D Ritchie; Tatania V Macfarlane; Colin R Simpson; Syed Ahmed; Chris Robertson; Stuart C Clarke
Journal:  BMC Infect Dis       Date:  2008-04-23       Impact factor: 3.090
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.